Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 199

1.

Epigenetic Associations with Estimated Glomerular Filtration Rate (eGFR) among Men with HIV Infection.

Chen J, Huang Y, Hui Q, Mathur R, Gwinn M, So-Armah K, Freiberg MS, Justice AC, Xu K, Marconi VC, Sun YV.

Clin Infect Dis. 2019 Mar 20. pii: ciz240. doi: 10.1093/cid/ciz240. [Epub ahead of print]

PMID:
30893429
2.

The Next Generation Blueprint of Computational Toxicology at the U.S. Environmental Protection Agency.

Thomas RS, Bahadori T, Buckley TJ, Cowden J, Deisenroth C, Dionisio KL, Frithsen JB, Grulke CM, Gwinn MR, Harrill JA, Higuchi M, Houck KA, Hughes MF, Hunter ES, Isaacs KK, Judson RS, Knudsen TB, Lambert JC, Linnenbrink M, Martin TM, Newton SR, Padilla S, Patlewicz G, Paul-Friedman K, Phillips KA, Richard AM, Sams R, Shafer TJ, Setzer RW, Shah I, Simmons JE, Simmons SO, Singh A, Sobus JR, Strynar M, Swank A, Tornero-Valez R, Ulrich EM, Villeneuve DL, Wambaugh JF, Wetmore BA, Williams AJ.

Toxicol Sci. 2019 Jun 1;169(2):317-332. doi: 10.1093/toxsci/kfz058.

PMID:
30835285
3.

Next-Generation Sequencing of Infectious Pathogens.

Gwinn M, MacCannell D, Armstrong GL.

JAMA. 2019 Feb 14. doi: 10.1001/jama.2018.21669. [Epub ahead of print] No abstract available.

PMID:
30763433
4.

DNA Methylation Markers of Type 2 Diabetes Mellitus Among Male Veterans With or Without Human Immunodeficiency Virus Infection.

Mathur R, Hui Q, Huang Y, Gwinn M, So-Armah K, Freiberg MS, Justice AC, Xu K, Marconi VC, Sun YV.

J Infect Dis. 2019 May 24;219(12):1959-1962. doi: 10.1093/infdis/jiz023.

PMID:
30649532
5.

Restrictive versus liberal red blood cell transfusion for cardiac surgery: a systematic review and meta-analysis of randomized controlled trials.

Kheiri B, Abdalla A, Osman M, Haykal T, Chintalapati S, Cranford J, Sotzen J, Gwinn M, Ahmed S, Hassan M, Bachuwa G, Bhatt DL.

J Thromb Thrombolysis. 2019 Feb;47(2):179-185. doi: 10.1007/s11239-018-1784-1.

PMID:
30511259
6.

Drug-eluting versus bare-metal stents in older patients: A meta-analysis of randomized controlled trials.

Kheiri B, Osman M, Abdalla A, Haykal T, Chahine A, Gwinn M, Ahmed S, Hassan M, Bachuwa G, Bhatt DL.

Cardiovasc Revasc Med. 2018 Nov 7. pii: S1553-8389(18)30494-9. doi: 10.1016/j.carrev.2018.11.005. [Epub ahead of print]

PMID:
30446398
7.

Epidemiology: a foundation of environmental decision making.

Deener KCK, Sacks JD, Kirrane EF, Glenn BS, Gwinn MR, Bateson TF, Burke TA.

J Expo Sci Environ Epidemiol. 2018 Nov;28(6):515-521. doi: 10.1038/s41370-018-0059-4. Epub 2018 Sep 5. Review.

PMID:
30185947
8.

Accelerating the Pace of Chemical Risk Assessment.

Kavlock RJ, Bahadori T, Barton-Maclaren TS, Gwinn MR, Rasenberg M, Thomas RS.

Chem Res Toxicol. 2018 May 21;31(5):287-290. doi: 10.1021/acs.chemrestox.7b00339. Epub 2018 Apr 6. Review.

PMID:
29600706
9.

From public health genomics to precision public health: a 20-year journey.

Khoury MJ, Bowen MS, Clyne M, Dotson WD, Gwinn ML, Green RF, Kolor K, Rodriguez JL, Wulf A, Yu W.

Genet Med. 2018 Jun;20(6):574-582. doi: 10.1038/gim.2017.211. Epub 2017 Dec 14. Review.

10.

A critical evaluation of the algorithm behind the Relative Citation Ratio (RCR).

Janssens ACJW, Goodman M, Powell KR, Gwinn M.

PLoS Biol. 2017 Oct 2;15(10):e2002536. doi: 10.1371/journal.pbio.2002536. eCollection 2017 Oct. No abstract available.

11.

Chemical Risk Assessment: Traditional vs Public Health Perspectives.

Gwinn MR, Axelrad DA, Bahadori T, Bussard D, Cascio WE, Deener K, Dix D, Thomas RS, Kavlock RJ, Burke TA.

Am J Public Health. 2017 Jul;107(7):1032-1039. doi: 10.2105/AJPH.2017.303771. Epub 2017 May 18.

12.

Integrating Advanced Molecular Technologies into Public Health.

Gwinn M, MacCannell DR, Khabbaz RF.

J Clin Microbiol. 2017 Mar;55(3):703-714. doi: 10.1128/JCM.01967-16. Epub 2016 Dec 28. Review.

13.

A knowledge base for tracking the impact of genomics on population health.

Yu W, Gwinn M, Dotson WD, Green RF, Clyne M, Wulf A, Bowen S, Kolor K, Khoury MJ.

Genet Med. 2016 Dec;18(12):1312-1314. doi: 10.1038/gim.2016.63. Epub 2016 Jun 9.

14.

Erratum to: Novel citation-based search method for scientific literature: application to meta-analyses.

Janssens AC, Gwinn M.

BMC Med Res Methodol. 2015 Nov 10;15:97. doi: 10.1186/s12874-015-0093-z. No abstract available.

15.

Novel citation-based search method for scientific literature: application to meta-analyses.

Janssens AC, Gwinn M.

BMC Med Res Methodol. 2015 Oct 13;15:84. doi: 10.1186/s12874-015-0077-z. Erratum in: BMC Med Res Methodol. 2015;15:97.

16.

Editorial: Updated guidance on human genome epidemiology (HuGE) reviews and meta-analyses of genetic associations.

Gwinn M, Ioannidis JP, Little J, Khoury MJ.

Am J Epidemiol. 2014 Sep 15;180(6):559-61. doi: 10.1093/aje/kwu196. Epub 2014 Aug 26. No abstract available.

PMID:
25164421
17.

Strategies, actions, and outcomes of pilot state programs in public health genomics, 2003-2008.

St Pierre J, Bach J, Duquette D, Oehlke K, Nystrom R, Silvey K, Zlot A, Giles R, Johnson J, Anders HM, Gwinn M, Bowen S, Khoury MJ.

Prev Chronic Dis. 2014 Jun 12;11:E97. doi: 10.5888/pcd11.130267.

18.

Human health effects of tetrachloroethylene: key findings and scientific issues.

Guyton KZ, Hogan KA, Scott CS, Cooper GS, Bale AS, Kopylev L, Barone S, Makris SL, Glenn B, Subramaniam RP, Gwinn MR, Dzubow RC, Chiu WA.

Environ Health Perspect. 2014 Apr;122(4):325-34. doi: 10.1289/ehp.1307359. Epub 2014 Feb 14.

19.

Horizon scanning for translational genomic research beyond bench to bedside.

Clyne M, Schully SD, Dotson WD, Douglas MP, Gwinn M, Kolor K, Wulf A, Bowen MS, Khoury MJ.

Genet Med. 2014 Jul;16(7):535-8. doi: 10.1038/gim.2013.184. Epub 2014 Jan 9.

20.

Prioritizing genomic applications for action by level of evidence: a horizon-scanning method.

Dotson WD, Douglas MP, Kolor K, Stewart AC, Bowen MS, Gwinn M, Wulf A, Anders HM, Chang CQ, Clyne M, Lam TK, Schully SD, Marrone M, Feero WG, Khoury MJ.

Clin Pharmacol Ther. 2014 Apr;95(4):394-402. doi: 10.1038/clpt.2013.226. Epub 2014 Feb 19. Review.

21.

A systematic review of cancer GWAS and candidate gene meta-analyses reveals limited overlap but similar effect sizes.

Chang CQ, Yesupriya A, Rowell JL, Pimentel CB, Clyne M, Gwinn M, Khoury MJ, Wulf A, Schully SD.

Eur J Hum Genet. 2014 Mar;22(3):402-8. doi: 10.1038/ejhg.2013.161. Epub 2013 Jul 24.

22.

Viral hepatitis C gets personal--the value of human genomics to public health.

Zhang L, Gwinn M, Hu DJ.

Public Health Genomics. 2013;16(4):192-7. doi: 10.1159/000352014. Epub 2013 Jul 11. Review.

23.

Human health effects of trichloroethylene: key findings and scientific issues.

Chiu WA, Jinot J, Scott CS, Makris SL, Cooper GS, Dzubow RC, Bale AS, Evans MV, Guyton KZ, Keshava N, Lipscomb JC, Barone S Jr, Fox JF, Gwinn MR, Schaum J, Caldwell JC.

Environ Health Perspect. 2013 Mar;121(3):303-11. doi: 10.1289/ehp.1205879. Epub 2012 Dec 18. Review.

24.

Comprehensive environmental assessment: a meta-assessment approach.

Powers CM, Dana G, Gillespie P, Gwinn MR, Hendren CO, Long TC, Wang A, Davis JM.

Environ Sci Technol. 2012 Sep 4;46(17):9202-8. doi: 10.1021/es3023072. Epub 2012 Aug 13.

25.

A population approach to precision medicine.

Khoury MJ, Gwinn ML, Glasgow RE, Kramer BS.

Am J Prev Med. 2012 Jun;42(6):639-45. doi: 10.1016/j.amepre.2012.02.012.

26.

Knowledge integration at the center of genomic medicine.

Khoury MJ, Gwinn M, Dotson WD, Schully SD.

Genet Med. 2012 Jul;14(7):643-7.

27.

Trends in population-based studies of human genetics in infectious diseases.

Rowell JL, Dowling NF, Yu W, Yesupriya A, Zhang L, Gwinn M.

PLoS One. 2012;7(2):e25431. doi: 10.1371/journal.pone.0025431. Epub 2012 Feb 7.

28.

Use of family history in clinical guidelines for diabetes and colorectal cancer.

Peterson BA, Gwinn ML, Valdez RA.

Am J Prev Med. 2012 Jan;42(1):65-70. doi: 10.1016/j.amepre.2011.08.017.

PMID:
22176849
29.

A pilot study of host genetic variants associated with influenza-associated deaths among children and young adults.

Ferdinands JM, Denison AM, Dowling NF, Jost HA, Gwinn ML, Liu L, Zaki SR, Shay DK.

Emerg Infect Dis. 2011 Dec;17(12):2294-302. doi: 10.3201/eid1712.111002.

30.

Genetic epidemiology with a capital E, ten years after.

Khoury MJ, Gwinn M, Clyne M, Yu W.

Genet Epidemiol. 2011 Dec;35(8):845-52. doi: 10.1002/gepi.20634. Review.

PMID:
22125223
31.

Beyond base pairs to bedside: a population perspective on how genomics can improve health.

Khoury MJ, Gwinn M, Bowen MS, Dotson WD.

Am J Public Health. 2012 Jan;102(1):34-7. doi: 10.2105/AJPH.2011.300299. Epub 2011 Nov 28.

32.

Meeting report: mode(s) of action of asbestos and related mineral fibers.

Gwinn MR, DeVoney D, Jarabek AM, Sonawane B, Wheeler J, Weissman DN, Masten S, Thompson C.

Environ Health Perspect. 2011 Dec;119(12):1806-10. doi: 10.1289/ehp.1003240. Epub 2011 Aug 1.

33.

Is there a need for PGxceptionalism?

Khoury MJ, Gwinn M, Dotson WD, Bowen MS.

Genet Med. 2011 Oct;13(10):866-7. doi: 10.1097/GIM.0b013e3182265bed. No abstract available.

PMID:
21799428
34.

Sodium and potassium intake and mortality among US adults: prospective data from the Third National Health and Nutrition Examination Survey.

Yang Q, Liu T, Kuklina EV, Flanders WD, Hong Y, Gillespie C, Chang MH, Gwinn M, Dowling N, Khoury MJ, Hu FB.

Arch Intern Med. 2011 Jul 11;171(13):1183-91. doi: 10.1001/archinternmed.2011.257.

PMID:
21747015
35.

GWAS Integrator: a bioinformatics tool to explore human genetic associations reported in published genome-wide association studies.

Yu W, Yesupriya A, Wulf A, Hindorff LA, Dowling N, Khoury MJ, Gwinn M.

Eur J Hum Genet. 2011 Oct;19(10):1095-9. doi: 10.1038/ejhg.2011.91. Epub 2011 May 25.

36.

Multiple modes of action of asbestos and related mineral fibers.

Gwinn MR.

J Toxicol Environ Health B Crit Rev. 2011;14(1-4):1-2. doi: 10.1080/10937404.2011.556044. No abstract available.

37.

Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration.

Janssens AC, Ioannidis JP, Bedrosian S, Boffetta P, Dolan SM, Dowling N, Fortier I, Freedman AN, Grimshaw JM, Gulcher J, Gwinn M, Hlatky MA, Janes H, Kraft P, Melillo S, O'Donnell CJ, Pencina MJ, Ransohoff D, Schully SD, Seminara D, Winn DM, Wright CF, van Duijn CM, Little J, Khoury MJ.

Eur J Clin Invest. 2011 Sep;41(9):1010-35. doi: 10.1111/j.1365-2362.2011.02493.x. Epub 2011 Mar 15.

PMID:
21434890
38.

Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration.

Janssens AC, Ioannidis JP, Bedrosian S, Boffetta P, Dolan SM, Dowling N, Fortier I, Freedman AN, Grimshaw JM, Gulcher J, Gwinn M, Hlatky MA, Janes H, Kraft P, Melillo S, O'Donnell CJ, Pencina MJ, Ransohoff D, Schully SD, Seminara D, Winn DM, Wright CF, van Duijn CM, Little J, Khoury MJ.

Eur J Epidemiol. 2011 Apr;26(4):313-37. doi: 10.1007/s10654-011-9551-z.

39.

Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS): explanation and elaboration.

Janssens AC, Ioannidis JP, Bedrosian S, Boffetta P, Dolan SM, Dowling N, Fortier I, Freedman AN, Grimshaw JM, Gulcher J, Gwinn M, Hlatky MA, Janes H, Kraft P, Melillo S, O'Donnell CJ, Pencina MJ, Ransohoff D, Schully SD, Seminara D, Winn DM, Wright CF, van Duijn CM, Little J, Khoury MJ.

J Clin Epidemiol. 2011 Aug;64(8):e1-e22. doi: 10.1016/j.jclinepi.2011.02.003. Epub 2011 Mar 16.

PMID:
21414753
40.

Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration.

Janssens AC, Ioannidis JP, Bedrosian S, Boffetta P, Dolan SM, Dowling N, Fortier I, Freedman AN, Grimshaw JM, Gulcher J, Gwinn M, Hlatky MA, Janes H, Kraft P, Melillo S, O'Donnell CJ, Pencina MJ, Ransohoff D, Schully SD, Seminara D, Winn DM, Wright CF, van Duijn CM, Little J, Khoury MJ.

Eur J Hum Genet. 2011 May;19(5):18 p preceding 494. doi: 10.1038/ejhg.2011.27.

41.

FDA workshop on emerging infectious diseases: evaluating emerging infectious diseases (EIDs) for transfusion safety.

Atreya C, Nakhasi H, Mied P, Epstein J, Hughes J, Gwinn M, Kleinman S, Dodd R, Stramer S, Walderhaug M, Ganz P, Goodrich R, Tibbetts C, Asher D.

Transfusion. 2011 Aug;51(8):1855-71. doi: 10.1111/j.1537-2995.2011.03084.x. Epub 2011 Mar 10. No abstract available.

PMID:
21392016
42.

A review of the genotoxicity of 1,2-dichloroethane (EDC).

Gwinn MR, Johns DO, Bateson TF, Guyton KZ.

Mutat Res. 2011 Jan-Apr;727(1-2):42-53. doi: 10.1016/j.mrrev.2011.01.001. Epub 2011 Jan 19. Review.

PMID:
21255676
43.

Horizon scanning for new genomic tests.

Gwinn M, Grossniklaus DA, Yu W, Melillo S, Wulf A, Flome J, Dotson WD, Khoury MJ.

Genet Med. 2011 Feb;13(2):161-5. doi: 10.1097/GIM.0b013e3182011661.

PMID:
21233720
44.

Meeting report: Estimating the benefits of reducing hazardous air pollutants--summary of 2009 workshop and future considerations.

Gwinn MR, Craig J, Axelrad DA, Cook R, Dockins C, Fann N, Fegley R, Guinnup DE, Helfand G, Hubbell B, Mazur SL, Palma T, Smith RL, Vandenberg J, Sonawane B.

Environ Health Perspect. 2011 Jan;119(1):125-30. doi: 10.1289/ehp.1002468. Epub 2010 Oct 4.

45.

PLoS currents: evidence on genomic tests - At the crossroads of translation.

Gwinn M, Dotson WD, Khoury MJ.

PLoS Curr. 2010 Sep 2;2. pii: RRN1179. doi: 10.1371/currents.RRN1179.

46.

The emergence of translational epidemiology: from scientific discovery to population health impact.

Khoury MJ, Gwinn M, Ioannidis JP.

Am J Epidemiol. 2010 Sep 1;172(5):517-24. doi: 10.1093/aje/kwq211. Epub 2010 Aug 5.

47.

Future health applications of genomics: priorities for communication, behavioral, and social sciences research.

McBride CM, Bowen D, Brody LC, Condit CM, Croyle RT, Gwinn M, Khoury MJ, Koehly LM, Korf BR, Marteau TM, McLeroy K, Patrick K, Valente TW.

Am J Prev Med. 2010 May;38(5):556-65. doi: 10.1016/j.amepre.2010.01.027.

48.

Application of support vector machine modeling for prediction of common diseases: the case of diabetes and pre-diabetes.

Yu W, Liu T, Valdez R, Gwinn M, Khoury MJ.

BMC Med Inform Decis Mak. 2010 Mar 22;10:16. doi: 10.1186/1472-6947-10-16.

49.

Human genomics and preparedness for infectious threats.

Dowling NF, Gwinn M, Mawle A.

Genome Med. 2009 Dec 29;1(12):119. doi: 10.1186/gm119.

50.

Risk management of nanomaterials.

Gwinn MR, Tran L.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010 Mar-Apr;2(2):130-7. doi: 10.1002/wnan.57. Review.

PMID:
20077523

Supplemental Content

Support Center